Detection of New Adverse Drug Reactions

Author is a pharmacovigilance consultant, Hertfordshire, UK. Reference for pharmaceutical companies and pharmacologists on the safety aspects of clinical drug development. Contains new chapters on legal aspects of pharmacovigilance, statistics for safety data, quality of life and drug therapy, and more. For researchers, students, and physicians. Previous edition: c1993.